... body radiotherapy for stage I non- smallcelllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana ... base) for purposes ofcontouring will begin at the level of the inferior aspect of the aortic arch (aorto-pulmonary window) and extendinferiorly tothe apex of the heart. The defined ipsilateral ... protocolRecommendations for implementing stereotactic radiotherapy in peripheral stage IA non- smallcelllung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL studyCoen...
... Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non- smallCellLungCancer Collaborative Group: Chemotherapyin nonsmallcelllung cancer: a meta-analysis ... G,Gozzelino F, Tonato M: Gemcitabine and cisplatin versus mito-mycin, ifosfamide, and cisplatin in advanced non- small- cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. ... cisplatin-teniposide in patients withadvanced non- small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 1998, 16:2133-2141.7....
... Non- small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non- small- cell lung cancer: ... for the detection ofEGFR mutations in non- small- celllung cancer. Clin Cancer Res 2009,15:3023-3028.13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,Travis WD: Lung ... chain reaction for the detection of mutations and deletionsin the epidermal growth factor receptor gene: applications of thismethod for the diagnosis of non- small- celllung cancer. Clin Chim...
... marker expression in tumor cells versus stromal cells in non smallcelllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... according to NSCLC histology. LungCancer 2010.31. Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM:Prognostic impact of platelet-derived growth factors in non- small cell lungcancer ... in the cytoplasm of most neo-plastic tumor cells and to a lesser extent expressed in the cytoplasm of normal epithelial cells in lung tissue.Based on m orphological cr iteria, infla mmatory cells(macrophages,...
... is the most com-mon and the most life-threatening form of cancer in Scot-land [2]. Lungcancer is also a major cause of deaththroughout the rest of the world [3,4]. Non- smallcelllungcancer ... breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for International Cancer ... Staging of small cell and non- smallcelllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ...
... cancers and the leading cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). ... sensitivity to gefitinib in non- smallcelllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non- small- celllungcancer ... EGFR-TKIs therapy. Key words: non- smallcelllung cancer, EGFR, somatic mutation, tyrosine kinase inhibitor, gene amplification Introduction Lung cancer is one of the most common human cancers...
... chemotherapy resulted in further tumorshrinkage, with no additional toxicity, and gave the patient the possibility to undergo a lobectomy ratherthan a pneumectomy, with the obvious advantages of ... Defining the optimal treatment for patients with inoperable nonsmallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, preoperative chemotherapy ... responses. Failure to obtain a response after the first few cycles should notautomatically discourage to continue treatment.IntroductionIn non- smallcelllungcancer (NSCLC), mediastinallymphnode...
... models The total normal lung volume was defined as the total lung volume minus the primary GTV and volume of the trachea and main bronchi. From each lung DVH, the fol-lowing dosimetric factors ... V10 are the useful indicators for predicting SARP in NSCLC patients treated with concurrent chemotherapy and IMRT.Background Lung cancer is the leading cause of cancer- related deathin the urban ... CC: Dose-volume factors contributing to the incidence of radiation pneumonitis in non- small- celllungcancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat...
... radiotherapy of non- small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non- small ... radiotherapyin treatment of stage I non- smallcelllung cancer. LungCancer 2003,41:1-11.17. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M: Variation in the hypoxic fraction among mouse tumors ... withour prospective hypothesis-driven protocol.MethodsEligibility Criteria The eligibility criteria were as follows: histologi cally-confirmed non- smallcelllungcancer (NSCLC)* Correspondence:...
... Stereotactic Body Rad iotherapy, Oligometastases, Non- SmallCellLung Cancer Background Non- smallcelllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients ... Milano1*AbstractBackground: Standard therapy for metastatic nonsmallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies of patients with limited metastases ... progression and was postulated to be a poor prognostic factor in lung cancer. Similarly,Bradley et al. demonstrated the prognostic value ofGTV determined on planning CT scans to be associatedwith OS...
... GMM, Jeremic B:Report from the international atomic energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non- smallcelllungcancer (NSCLC). Int J Radiat ... whentreating non- smallcelllung carcinoma (NSCLC) to deliver 40 to 50 Gy tothe uninvolved regional lymphnodes. Known as elective nodal irradiation (ENI), thistherapy is targeted to ipsilateral ... Organization forResearch and Treatment of Cancer, National Cancer Insti-tute of the United States, National Cancer Institute of Can- ada. J Natl Cancer Inst 2000, 93(3):205-216.7. Rosenzweig...
... of the elastic deformation (Nu) set to 0.3] theninterpolates the surface deformation tothe entire volume to derive a volumetric deformation field. The deformationmap was then applied tothe ... transformation of the middle image into the left image based on the mesh points on the surface of the GTV: note the distortion of the pulmonary structuresFigure 8Illustration of the consequences ... meshes. The contours of the macroscopic primary tumor in the planning CT and the follow-up CT are shown in red. Note the distortion of the vertebral body and the trachea without using meshes of these...
... stage I non- smallcelllung cancer. LungCancer 1999, 26:137-142.23. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation inearly stage (T1-2N0) non- smallcelllung cancer. RadiotherOncol ... (range: 1.6 to 16.4 %) and 5.3% (range: 1.2 to 14.3%), respectively.Yet, these volumes and the planning target volumes werestill small in comparison tothe total volume of the lungsand, up to this ... were irradiated; with each of 33 patients, stage I non- small cell lungcancer (NSCLC) was subject to irradiation. The standard dose prescribed tothe isocenter was30 Gy with an axial safety margin...
... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patients with medically inoperable, early stage, non- smallcell lung cancer ... considered to have N1 diseaseclose tothe primary lung tumor. In 19 cases (59%) the tumor was in the right lung. In 22 cases (69%) the tumorwas located in the upper lobes.Radiotherapy was ... purposes)Background The use of accelerated hypofractionated radiation therapyis an attractive option for patients with early stage non- small celllungcancer (NSCLC) who are not surgical can- didates....
... purposes)BackgroundWorldwide and in Europe lungcancer is the most com-mon cause of cancer related-death with an increasing inci-dence each year. The majority of patients has Non- Small CellLungCancer (NSCLC) and ... stage I Nonsmall celllung carcinoma. Cancer 2004,101:1623-1631.54. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Leb-esque J: Acute esophageal toxicity in non- smallcelllung can- cer ... Post-operative chemotherapy for non- smallcelllung cancer: Asystematic review and meta-analysis. J Thorac Cardiovasc Surg2004, 128:414-419.39. The International Adjuvant LungCancer Collaborative...